Kyle Haug A Ikido Pharma Inc. (AIKI) insider trading activity
Kyle Haug is Director of AIkido Pharma Inc.. Currently has a direct ownership of 24,409 shares of AIKI, which is worth approximately $92,754. The most recent transaction as insider was on Feb 10, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
        Shares Held (Direct Ownership)
        24.4K
                  
          
      
      
    
                  
                    0%
                  
            3M change
          
                    
          
          
              
                n/a
              
             12M change
          
                    
        
        Total Value Held
          $92,754
      
      
    
        KH
    
    
    Kyle Haug
        Director
      
       
        
        New York, NY